Back

Recent evidence on ferric derisomaltose in heart failure.

29 June 2021 (11:58 - 12:05)
Organised by:
Congress Presentation Part of: Iron deficiency and heart failure - evidence is piling up - what's next? Treatment Open Access Heart Failure 2021

About the speaker

Photo
Doctor Andrew Ambrosy

Kaiser Permanente, San Francisco Medical Centre and Medical Offices, San Francisco (United States of America)

6 More presentations in this session

Presentation thumbnail
Introduction and welcome.
Professor J. Cleland (Glasgow, GB)
Video
Presentation thumbnail
Functional and clinical outcomes with IV iron so far.
Professor P. Van Der Meer (Groningen, NL)
Video
Presentation thumbnail
Live Q&A.
Video
Presentation thumbnail
Live Q&A.
Presentation thumbnail
What's in the IV iron trial pipeline and what will it add?
Professor P. Kalra (Portsmouth, GB)
Video

Access the full session

Session thumbnail
Iron deficiency and heart failure - evidence is piling up - what's next?
Video

The Event

Event poster

Heart Failure 2021

29 June 2021 11:58 CET
You may be interested in
thumbnail
Congress Presentation
Clinical experience and safety of ferric carboxymaltose for treating iron deficiency in heart failure patients with mildly reduced and preserved left ventricular ejection fraction.
20 May 2023
thumbnail
Congress Session
Editor's Choice: report from the heart failure sections of ESC Journal Family and overview of the ESC Textbook of Heart Failure
18 May 2025
thumbnail
Congress Session
Two decades of research on iron deficiency in heart failure: looking back and moving forward
21 May 2023
thumbnail
Congress Session
Late-breaking clinical trials in chronic heart failure
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources